$INVU
Investview, Inc.

2024 Q4 Form 10-Q Financial Statement

#000149315224045065 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $11.74M
YoY Change -38.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.048M
YoY Change -18.33%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $12.44M
YoY Change -26.5%
Operating Profit -$698.5K
YoY Change -131.14%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$16.87K
YoY Change -124.16%
Pretax Income -$715.4K
YoY Change -130.93%
Income Tax $95.29K
% Of Pretax Income
Net Earnings -$810.6K
YoY Change -140.36%
Net Earnings / Revenue -6.9%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 1.859B shares 1.861B shares
Diluted Shares Outstanding 1.861B shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $24.45M
Short-Term Investments
Other Short-Term Assets $461.7K
YoY Change -77.45%
Inventory $0.00
Prepaid Expenses $319.7K
Receivables $1.872M
Other Receivables
Total Short-Term Assets $30.79M
YoY Change 10.0%
LONG-TERM ASSETS
Property, Plant & Equipment $2.048M
YoY Change -73.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $76.59K
YoY Change -97.32%
Total Long-Term Assets $2.125M
YoY Change -79.95%
TOTAL ASSETS
Total Short-Term Assets $30.79M
Total Long-Term Assets $2.125M
Total Assets $32.92M
YoY Change -14.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue $2.365M
YoY Change -15.66%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.37M
YoY Change -3.88%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $2.356M
YoY Change -60.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.37M
Total Long-Term Liabilities $2.356M
Total Liabilities $15.73M
YoY Change -21.13%
SHAREHOLDERS EQUITY
Retained Earnings -$86.80M
YoY Change -0.45%
Common Stock $1.859M
YoY Change -20.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.19M
YoY Change
Total Liabilities & Shareholders Equity $32.92M
YoY Change -14.7%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$810.6K
YoY Change -140.36%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
977418 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-180223 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2031269 usd
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000862651
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20912276 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
230354 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
319723 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
492607 usd
CY2024Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
2480704 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
2232725 usd
CY2024Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
2533538 usd
CY2024Q3 INVU Income Tax Paid In Advance
IncomeTaxPaidInAdvance
543292 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
461674 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
585632 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
30791833 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
24453594 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2047943 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6536823 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34633 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
110427 usd
CY2024Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
41954 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2588127 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76587 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2698554 usd
CY2024Q3 us-gaap Assets
Assets
32916363 usd
CY2023Q4 us-gaap Assets
Assets
33688971 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8755185 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5854093 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
127696 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
187419 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
301161 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1004535 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2365008 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2703398 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5732 usd
CY2024Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
250905 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41275 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
109628 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13370365 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12039571 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
252192 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
252192 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
252192 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
252192 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
252 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
252 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1859231786 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1859231786 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2333356496 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2333356496 shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104056807 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23218 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23218 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86799265 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87576899 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
17190494 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18790298 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32916363 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33688971 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11742881 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19169640 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40521479 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49994127 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1257569 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3147890 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7614768 usd
CY2024Q3 INVU Commissions
Commissions
6270310 usd
CY2023Q3 INVU Commissions
Commissions
9272024 usd
INVU Commissions
Commissions
19988364 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16751 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7410 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
548559 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
536464 usd
CY2024Q3 us-gaap Salaries And Wages
SalariesAndWages
1471649 usd
CY2023Q3 us-gaap Salaries And Wages
SalariesAndWages
1714299 usd
us-gaap Salaries And Wages
SalariesAndWages
4859463 usd
us-gaap Salaries And Wages
SalariesAndWages
5416292 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
416410 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
285133 usd
us-gaap Professional Fees
ProfessionalFees
1201406 usd
us-gaap Professional Fees
ProfessionalFees
1202674 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
usd
CY2023Q4 INVU Income Tax Paid In Advance
IncomeTaxPaidInAdvance
usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2024Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2024Q3 INVU Common Stock Canceled
CommonStockCanceled
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
INVU Increase Decrease Customer Advances
IncreaseDecreaseCustomerAdvances
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
INVU Derivative Liability Extinguished With Warrant Exercise
DerivativeLiabilityExtinguishedWithWarrantExercise
usd
INVU Shares Forfeited
SharesForfeited
usd
INVU Recognition Of Lease Liability And Rou Asset At Lease Commencement
RecognitionOfLeaseLiabilityAndROUAssetAtLeaseCommencement
usd
INVU Cryptocurrency Received From Sale Of Fixed Assets
CryptocurrencyReceivedFromSaleOfFixedAssets
usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
INVU Derivative Liability Recorded On New Instruments
DerivativeLiabilityRecordedOnNewInstruments
usd
INVU Derivative Liability Reduced By Warrant Exercise
DerivativeLiabilityReducedByWarrantExercise
usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
INVU Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
INVU Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Canceled
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceCanceled
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
INVU Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-27019
dei Entity Registrant Name
EntityRegistrantName
Investview, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0369205
dei Entity Address Address Line1
EntityAddressAddressLine1
521 West Lancaster Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Second Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Haverford
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19041
dei City Area Code
CityAreaCode
732
dei Local Phone Number
LocalPhoneNumber
889-4300
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1859231786 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24452902 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
298 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
256392 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6048 usd
CY2024Q3 INVU Accrued Liabilities Long Term
AccruedLiabilitiesLongTerm
446394 usd
CY2023Q4 INVU Accrued Liabilities Long Term
AccruedLiabilitiesLongTerm
1189643 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2355504 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2859102 usd
CY2024Q3 us-gaap Liabilities
Liabilities
15725869 usd
CY2023Q4 us-gaap Liabilities
Liabilities
14898673 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1859232 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2333356 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102153493 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4703513 usd
INVU Commissions
Commissions
24005229 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
977418 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-184221 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2500129 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6435522 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7190383 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
12441376 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
16926885 usd
us-gaap Operating Expenses
OperatingExpenses
38894468 usd
us-gaap Operating Expenses
OperatingExpenses
46150031 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-698495 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2242755 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1627011 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3844096 usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2034 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
11939 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
5434 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
15596 usd
CY2024Q3 us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
1558 usd
CY2023Q3 us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
-58401 usd
us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
284112 usd
us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
170444 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
294862 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
431603 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1284021 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1027108 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16866 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
69821 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
629557 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
270116 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-715361 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2312576 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2256568 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4114212 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
95287 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
304262 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
864429 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100599 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-810648 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2008314 usd
us-gaap Net Income Loss
NetIncomeLoss
1392139 usd
us-gaap Net Income Loss
NetIncomeLoss
3013613 usd
CY2024Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
204835 usd
CY2023Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
204835 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
614505 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
614505 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1015483 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1803479 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
777634 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2399108 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1860677438 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2632983119 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1924667422 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2635166049 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1860677438 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3669411690 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2961095993 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3671594620 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17374576 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
768613 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
23 usd
CY2023Q1 INVU Adjustments To Additional Paid In Capital Derivative Liability Extinguished For Warrants Exercised
AdjustmentsToAdditionalPaidInCapitalDerivativeLiabilityExtinguishedForWarrantsExercised
3 usd
CY2023Q1 us-gaap Dividends
Dividends
204835 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
407894 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
18346274 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
628615 usd
CY2023Q2 us-gaap Dividends
Dividends
204835 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
597405 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
19367459 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
649455 usd
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-3172380 usd
CY2023Q3 us-gaap Dividends
Dividends
204835 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2008314 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18648013 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18790298 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
430760 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-3571146 usd
CY2024Q1 us-gaap Dividends
Dividends
204835 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1669940 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
17115017 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
440915 usd
CY2024Q2 us-gaap Dividends
Dividends
204835 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
532847 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
17883944 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
322033 usd
CY2024Q3 us-gaap Dividends
Dividends
204835 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-810648 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
17190494 usd
us-gaap Net Income Loss
NetIncomeLoss
1392139 usd
us-gaap Net Income Loss
NetIncomeLoss
3013613 usd
us-gaap Depreciation
Depreciation
3337595 usd
us-gaap Depreciation
Depreciation
3258738 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
253557 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
252632 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1193708 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2046683 usd
INVU Gain Losson Lease Cost Netof Repayment
GainLossonLeaseCostNetofRepayment
-1393 usd
INVU Gain Losson Lease Cost Netof Repayment
GainLossonLeaseCostNetofRepayment
-7648 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-180223 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-184221 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
5434 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
15596 usd
us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
284112 usd
us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
170444 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
977418 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
247979 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
670216 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-74645 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-172884 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
665315 usd
INVU Increase Decrease In Income Tax Paid In Advance
IncreaseDecreaseInIncomeTaxPaidInAdvance
-543292 usd
INVU Increase Decrease In Income Tax Paid In Advance
IncreaseDecreaseInIncomeTaxPaidInAdvance
451399 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-169034 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1142470 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-12635 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
2114529 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1055794 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-38621 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-703374 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4799 usd
INVU Increase Decrease Customer Advances
IncreaseDecreaseCustomerAdvances
-96609 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-338390 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
729408 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
14075 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
14024 usd
INVU Increase Decrease In Interest Payable Related Parties Net
IncreaseDecreaseInInterestPayableRelatedPartiesNet
676377 usd
INVU Increase Decrease In Interest Payable Related Parties Net
IncreaseDecreaseInInterestPayableRelatedPartiesNet
676377 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7314251 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5800387 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
23278 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6356 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2529237 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6356 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2505959 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
675387 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
675387 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
296150 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
724130 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
2528820 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
497266 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
481075 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
23 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3997623 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1880569 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3310272 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1413859 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21142630 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21488898 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24452902 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22902757 usd
us-gaap Interest Paid Net
InterestPaidNet
697320 usd
us-gaap Interest Paid Net
InterestPaidNet
699757 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2111095 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
645500 usd
INVU Common Stock Repurchased For Payables
CommonStockRepurchasedForPayables
3571146 usd
INVU Common Stock Repurchased For Payables
CommonStockRepurchasedForPayables
3172380 usd
INVU Derivative Liability Extinguished With Warrant Exercise
DerivativeLiabilityExtinguishedWithWarrantExercise
3 usd
INVU Dividends Declared
DividendsDeclared
614505 usd
INVU Dividends Declared
DividendsDeclared
614505 usd
INVU Dividends Paid With Cryptocurrency
DividendsPaidWithCryptocurrency
122726 usd
INVU Dividends Paid With Cryptocurrency
DividendsPaidWithCryptocurrency
129650 usd
INVU Debt And Related Party Debt Extinguished In Exchange For Cryptocurrency
DebtAndRelatedPartyDebtExtinguishedInExchangeForCryptocurrency
116310 usd
INVU Debt And Related Party Debt Extinguished In Exchange For Cryptocurrency
DebtAndRelatedPartyDebtExtinguishedInExchangeForCryptocurrency
1484021 usd
INVU Shares Forfeited
SharesForfeited
1750 usd
INVU Recognition Of Lease Liability And Rou Asset At Lease Commencement
RecognitionOfLeaseLiabilityAndROUAssetAtLeaseCommencement
23520 usd
INVU Cryptocurrency Received From Sale Of Fixed Assets
CryptocurrencyReceivedFromSaleOfFixedAssets
9913 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_800_eus-gaap--NatureOfOperations_zbLrAHtI9dtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_007"></span>NOTE 1 – <span id="xdx_828_zXbbjitVMRa">ORGANIZATION AND NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organization</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investview, Inc. was incorporated on <span id="xdx_908_edei--EntityIncorporationDateOfIncorporation_dd_c20240101__20240930_zFFNvSY0OAu9" title="Entity incorporation, date of incorporation">January 30, 1946</span>, under the laws of the state of Utah as the Uintah Mountain Copper Mining Company. In January 2005, we changed domicile to Nevada and changed our name to Voxpath Holding, Inc. In September of 2006, we merged with The Retirement Solution Inc. and then changed our name to TheRetirementSolution.Com, Inc. Subsequently, in October 2008 we changed our name to Global Investor Services, Inc., before changing our name to Investview, Inc., on March 27, 2012.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 1, 2017, we closed on a Contribution Agreement with the members of Wealth Generators, LLC, a limited liability company (“Wealth Generators”), pursuant to which the Wealth Generators members contributed <span id="xdx_905_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20170401__us-gaap--TypeOfArrangementAxis__custom--ContributionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--WealthGeneratorsLLCMember_zJSjTqfkrc24" title="Percentage of shares contributed">100</span>% of the outstanding securities of Wealth Generators in exchange for an aggregate of <span id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20170401__20170401__us-gaap--TypeOfArrangementAxis__custom--ContributionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--WealthGeneratorsLLCMember_zK9aWS4GiJX4" title="Number of shares exchanged for common stock">1,358,670,942</span> shares of our common stock. Following this transaction, Wealth Generators became our wholly owned subsidiary, and the former members of Wealth Generators became our stockholders and controlled the majority of our outstanding common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 6, 2017, we entered into an Acquisition Agreement with Market Trend Strategies, LLC, a company whose members are also former members of our management. Under the Acquisition Agreement, we spun-off our operations that existed prior to the merger with Wealth Generators and sold the intangible assets used in those pre-merger operations in exchange for Market Trend Strategies’ assumption of $<span id="xdx_90A_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c20170606__20170606__us-gaap--TypeOfArrangementAxis__custom--AcquisitionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--MarketTrendStrategiesLLCMember_zMKNEfN3DD1g" title="Value pre-merger liabilities">419,139</span> in pre-merger liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 28, 2018, we filed a name change for Wealth Generators, LLC to Kuvera, LLC (“Kuvera”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2019, we renamed our non-operating wholly owned subsidiary WealthGen Global, LLC to SAFETek, LLC, a Utah limited liability company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2021, we filed a name change for Kuvera, LLC to iGenius, LLC (“iGenius”) and on February 2, 2021, we filed a name change for Kuvera (N.I.) Limited to iGenius Global LTD.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 20, 2021, the Board of Directors approved a change in our fiscal year from March 31 to December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">We operate a diversified financial technology services company offering several different lines of business, including a business unit that provides financial educational tools, content and research, through a global distribution network of independent distributors; and a business unit that offers digital products and services that support blockchain technologies and Bitcoin mining operations; and a business unit that manufactures and develops a collection of proprietary health, beauty and wellness products for its existing base of wholesale customers, and plans to expand its sales and marketing initiatives by developing and offering proprietary products through our global distribution network of independent distributors and direct to consumers platform. In addition, we plan to develop a business unit that will offer investors an online trading platform to enable self-directed retail brokerage services by integrating the early-stage online brokerage trading platform we acquired during March 2024, with the proprietary algorithmic trading platform we acquired in September 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1946-01-30
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zQzQWoljuwji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_z34wijMdzv38">Financial Statement Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_z8ZhcCdhhGSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zCXbPI8S0dD5">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zXtpMpvArr88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zObjUY2EvAU7">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially expose us to concentration of credit risk include cash and receivables. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit of $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20240930_zoSGyNUyPxb" title="Cash, FDIC insured amount">250,000</span>. As of September 30, 2024 and December 31, 2023, cash balances that exceeded FDIC limits were $<span id="xdx_90D_eus-gaap--CashUninsuredAmount_iI_c20240930_zs9Jqjs2wxIh" title="Cash balances exceeded FDIC limits">12,666,617</span> and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_iI_c20231231_zunviuZkyd2k" title="Cash balances exceeded FDIC limits">3,778,085</span>, respectively. We have not experienced significant losses relating to these concentrations in the past.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
12666617 usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
3778085 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24452902 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20912276 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
230354 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24452902 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21142630 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
722324 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1872000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
500000 usd
CY2024Q3 us-gaap Credit Card Receivables
CreditCardReceivables
1870000 usd
CY2024Q3 us-gaap Deposits Assets
DepositsAssets
2575492 usd
CY2023Q4 us-gaap Deposits Assets
DepositsAssets
2588127 usd
CY2024Q3 INVU Deposits Reclassified From Long Term Assets To Current Assets
DepositsReclassifiedFromLongTermAssetsToCurrentAssets
2533538 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12637414 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14096695 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10589471 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7559872 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2047943 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6536823 usd
us-gaap Depreciation
Depreciation
3337595 usd
us-gaap Depreciation
Depreciation
3258738 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
180223 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
26729 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
23278 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
6462 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
461674 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
585632 usd
us-gaap Crypto Asset Realized Gain Loss Operating
CryptoAssetRealizedGainLossOperating
284112 usd
us-gaap Crypto Asset Realized Gain Loss Operating
CryptoAssetRealizedGainLossOperating
-170444 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
977418 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2365008 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2703398 usd
INVU Gross Billingsreceipts
GrossBillingsreceipts
42869734 usd
INVU Refunds Incentives Credits And Chargebacks
RefundsIncentivesCreditsAndChargebacks
-2348255 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40521479 usd
INVU Gross Billingsreceipts
GrossBillingsreceipts
54097181 usd
INVU Refunds Incentives Credits And Chargebacks
RefundsIncentivesCreditsAndChargebacks
-3625554 usd
us-gaap Payments To Suppliers
PaymentsToSuppliers
477500 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49994127 usd
CY2024Q3 INVU Gross Billingsreceipts
GrossBillingsreceipts
12590830 usd
CY2024Q3 INVU Refunds Incentives Credits And Chargebacks
RefundsIncentivesCreditsAndChargebacks
-847949 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11742881 usd
CY2023Q3 INVU Gross Billingsreceipts
GrossBillingsreceipts
20663453 usd
CY2023Q3 INVU Refunds Incentives Credits And Chargebacks
RefundsIncentivesCreditsAndChargebacks
-1381813 usd
CY2023Q3 us-gaap Payments To Suppliers
PaymentsToSuppliers
112000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19169640 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
548559 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
536464 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4703513 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7614768 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
174835 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
0 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
0 usd
us-gaap Net Income Loss
NetIncomeLoss
1392139 usd
us-gaap Net Income Loss
NetIncomeLoss
3013613 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
614505 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
614505 usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
675387 usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
675387 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1453021 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3074495 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1924667422 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2635166049 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
471428571 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
471428571 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
565000000 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
565000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2961095993 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3671594620 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2008314 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
204835 usd
CY2023Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
225129 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2028608 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2632983119 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
471428571 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
565000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3669411690 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Operating Income Loss
OperatingIncomeLoss
1627011 usd
us-gaap Net Income Loss
NetIncomeLoss
1392139 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24452902 usd
INVU Working Capital
WorkingCapital
17421468 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
461674 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5732 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
5434 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
298 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
83196 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
81803 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y4M24D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
34227 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7833 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
42060 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
785 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
41275 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41275 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
252192 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
252192 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
252192 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
252192 shares
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
497266 usd
CY2024Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
250905 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10002 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10338 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1859231786 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1859231786 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2333356496 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2333356496 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
1000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10000000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
15000000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
360416665 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.05
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
11000000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.05
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
15000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.05
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.03
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
356416665 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.05
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.03
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
193291665 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.05
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M1D
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1203710 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2036345 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3700000 usd
INVU Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Vesting Period Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingVestingPeriodContractualTerm
P1Y6M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1178090 shares
CY2023Q4 INVU Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.10
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1178090 shares
CY2024Q3 INVU Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.10
CY2024Q3 INVU Warrants Exercisable
WarrantsExercisable
1178090 shares
CY2024Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P1Y4M20D
us-gaap Long Term Purchase Commitment Description
LongTermPurchaseCommitmentDescription
According to marketing and legal documents provided by such third-party provider, the product protection would allow the purchaser to protect its initial purchase price by obtaining 50% of its purchase price at five years or 100% of its purchase price at ten years.
CY2024Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
2480000 usd
CY2024Q3 us-gaap Credit Card Receivables
CreditCardReceivables
1870000 usd
CY2024Q3 us-gaap Credit Card Receivables
CreditCardReceivables
1870000 usd
CY2024Q3 us-gaap Credit Card Receivables
CreditCardReceivables
1870000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
95287 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
864429 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.133 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.383 pure
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
304262 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100599 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.132 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.268 pure
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-045065-index-headers.html Edgar Link pending
0001493152-24-045065-index.html Edgar Link pending
0001493152-24-045065.txt Edgar Link pending
0001493152-24-045065-xbrl.zip Edgar Link pending
ex21-01.htm Edgar Link pending
ex31-01.htm Edgar Link pending
ex31-02.htm Edgar Link pending
ex32-01.htm Edgar Link pending
ex32-02.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
invu-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
invu-20240930_cal.xml Edgar Link unprocessable
invu-20240930_lab.xml Edgar Link unprocessable
invu-20240930_def.xml Edgar Link unprocessable
invu-20240930_pre.xml Edgar Link unprocessable